Medicine - Definitions, History, and Regulation

Exam-Oriented Revision Sheet

1. 📌 Essentials

• Medicine: Substance with curative or preventive properties.
• Phology: Study of drugs' discovery, effects, and use.
• Pharmacopée: Official reference book defining raw material standards.
• Key historical milestones: Sumér tablets, Egyptian papyrus, Hippocrates, quinine, penicillin, chlorpromazine.
• Drug development phases: Preclinical (safety), clinical (efficacy), post-marketing surveillance.
• Regulatory bodies: ANSM (France), EMA (Europe); approval via AMM valid 5 years.
• Classification systems: ATC hierarchical system; forms include tablets, solutions, creams, injections.
• Sources of drugs: Natural (plants, animals, minerals), synthetic, biotechnological.
• Discovery methods: Observation, chance, error, rational design.
• Evidence levels: Meta-analyses, large RCTs (high); case series (low).
• Pharmacovigilance: Ongoing safety monitoring post-approval.

2. 🧩 Key Structures & Components

• Medicines: Active substances + excipients.
• Pharmacopée: Reference standards for purity and quality.
• Drug sources:
  • Plants (e.g., willow bark)
  • Animals (e.g., insulin)
  • Minerals (e.g., arsenic compounds)
  • Synthetic chemicals (e.g., aspirin)
  • Biotechnological products (e.g., monoclonal antibodies)
• Drug forms: Tablets, capsules, solutions, creams, injections.
• Routes of administration: Oral, subcutaneous, intramuscular, intravenous.
• Regulatory agencies: ANSM (France), EMA (Europe).
• Classification systems:
  • Anatomical (e.g., nervous system)
  • Therapeutic (e.g., antibiotics)
  • Chemical (e.g., benzodiazepines)
  • ATC code: hierarchical, e.g., N05BA01 (diazepam).

3. 🔬 Functions, Mechanisms & Relationships

• Discovery: Based on observation, chance, error, or rational design targeting specific biological pathways.
• Development:
  • Preclinical: safety, toxicity tests.
  • Clinical: efficacy, safety in humans (Phases I-IV).
• Mechanism of action:
  • Active principles bind to receptors, enzymes, or pathways.
  • Excipients aid stability, absorption, or administration.
• Regulation:
  • Approval (AMM) requires demonstration of safety, efficacy, and quality.
  • Post-marketing surveillance detects adverse effects.
• Hierarchy:
  • Natural/biological sources → Active ingredient → Formulation → Route of administration → Therapeutic effect.
• Evidence flow:

Discovery → Preclinical → Clinical trials (Phases I-IV) → Approval → Post-marketing surveillance

4. 📊 Comparative Table

5. 🗂️ Hierarchical Diagram (ASCII)

Medicines
 ├─ Natural Sources
 │    ├─ Plants
 │    ├─ Animals
 │    └─ Minerals
 ├─ Synthetic Drugs
 │    ├─ Semi-synthetic
 │    └─ Total synthesis
 └─ Biological & Biotechnological
      ├─ Insulin
      ├─ Monoclonal antibodies
      └─ Biosimilars

6. ⚠️ High-Yield Pitfalls & Confusions

• Confusing pharmacopée (reference book) with pharmacology (study).
• Mistaking natural remedies as inherently safe; many have toxicity.
• Overlooking the importance of regulatory approval (AMM) for safety and efficacy.
• Assuming all drugs are synthetic; many are natural or biotechnological.
• Misunderstanding prodrugs: inactive until metabolized.
• Confusing classification systems: chemical vs. therapeutic vs. anatomical.
• Ignoring post-marketing surveillance as a critical safety step.
• Overestimating evidence from small case series; high-level evidence needed.
• Mixing up discovery methods: chance vs. rational design.
• Assuming biosimilars are identical to original biologics (they are similar but not identical).

7. ✅ Final Exam Checklist

• Define medicine, pharmacology, and pharmacopée.
• Summarize key historical milestones in drug development.
• Describe the phases of clinical trials and their purpose.
• Explain the regulatory process for drug approval (AMM).
• Understand the ATC classification system and drug forms/routes.
• List natural and synthetic sources of drugs.
• Describe discovery methods: observation, chance, error, rational design.
• Recognize high vs. low evidence in clinical research.
• Identify main sources of drug information (VIDAL, PubMed, agencies).
• Understand post-marketing pharmacovigilance importance.
• Differentiate between biological, biosimilar, and chemical medicines.
• Know the concept of prodrugs and their purpose.
• Recall the main historical milestones: Hippocrates, quinine, penicillin, chlorpromazine.
• Be aware of the regulatory bodies (ANSM, EMA) and their roles.
• Comprehend the hierarchical organization from source to therapeutic effect.
• Recognize common pitfalls and confusions in drug classification and regulation.

This revision sheet condenses core concepts, structures, and relationships for effective exam preparation on medicines, their history, development, and regulation.